Too many food recalls
Food recalls for potentially deadly pathogens like Listeria, Salmonella, and E. coli are on the rise. The diagnostic tools for tracing these contaminations rely on outdated 100-year-old technology. Analysis takes 3-7 days in a specialized, off-site lab and cannot distinguish between a raging contamination and a single errant cell. It’s no wonder that it can take a food company months to find and verify the source of an outbreak. The longer it takes, the higher the financial risk. A single outbreak can cripple a large company and bankrupt smaller ones.
New technologies are needed to reduce the number and severity of outbreaks. Dozens of companies have tried. None have succeeded. Until SnapDNA.
SnapDNA: Faster, Safer, and Fresher
SnapDNA addresses the food industry’s most critical need: reducing the number and the severity of outbreaks, lowering production costs, and allowing fresher, safer food.
SnapDNA has the first self-contained, on-site analysis designed to replace all food pathogen lab tests. Results are available in 20 minutes and hundreds of samples can be analyzed per day. Unlike lab tests, SnapDNA provides quantitative data to reduce the time to find contaminations from months to days, enabling predictive analytics to help prevent outbreaks.
SnapDNA test results are available when product is ready to ship enabling fresher, safer food. Food companies save millions of dollars/year in storage costs and reduce exposure to contamination and recalls.
The right answers, right now
SnapDNA’s customer proven system reduces the time for a pathogen test from 3-7 days to 20 minutes. It works with any size sample, from a tablespoon to a few liters. Analysis is performed in self-contained, single-use cartridges; each acting as a miniature, computer-controlled laboratory. It can be operated almost anywhere, by almost anyone.
SnapDNA can be used where food is produced, packaged, or grown. It is as accurate as a lab test and much less susceptible to human error. Test results are uploaded to the cloud so food safety professionals can monitor all of their facilities in real-time and identify potential contamination events before product is shipped.
Tipping point technology
We have key strategic corporate partnerships...
“SnapDNA can save us dollars in an industry that measures margin in pennies. If anyone in my market adopts SnapDNA, we’ll all have to adopt to stay competitive”. – CEO of a protein company
“SnapDNA is a no-brainer. We spend $2M a year on pathogen tests and $3M on cold storage waiting 3 days for lab results”.
– VP Food Safety for a mid-size snack food company
...and government partnerships
The USDA will certify SnapDNA products for use by all government agencies and food inspection services. This certification is rare and highly advantageous. Food companies prefer to use the same test as regulators and inspectors.
SnapDNA has been selected by the most the most influential FoodTech accelerators.
Paid Pilots with Fortune 50 and Global 100 companies
SnapDNA has paid pilots with the world’s largest food companies, Nestle and PepsiCo. We are working closely with corporate R&D and global innovation teams as well as key decision makers in food safety and quality towards company-wide roll out because we solve business-critical problems.
SnapDNA has commitments from industry opinion shapers and category leaders in our targeted launch markets; Leafy greens/Produce and Poultry.
Revenue from each test performed
SnapDNA's business model is to sell single-use cartridges for each test performed at prices competitive with lab testing and provide analysis systems for a recurring monthly fee.
SnapDNA has personal, executive-level relationships with the 16 food companies we are initially targeting. These companies, along with Nestlé and PepsiCo operate over 1000 facilities. SnapDNA projects profitability with systems at just 70 facilities, which we expect to surpass in 2022. In addition, we plan to continually expand our menu of cartridges to detect E. coli, Salmonella and other pathogens.
Food safety testing is an existing $10B market
SnapDNA is addressing a major need in an established, recession-proof, $10 Billion market - Growing to $13 Billion in 3 years.
With SnapDNA, test results are available when the product is ready to ship. We can save a food company millions of dollars a year in storage cost alone. When contamination occurs, we dramatically reduce the risk and financial exposure from outbreaks and of recalls.
We listened and we delivered
SnapDNA has worked with food companies and solved one of the industry’s biggest technical challenges - on-site, rapid pathogen analysis that meets every requirement to replace lab testing. We know of nothing that comes close. SnapDNA detects only live cells from large, complex industry samples and, unlike lab testing, it can measure the number of pathogen cells in each sample - critical information when trying to determine the cause of a contamination. While the existence proof of SnapDNA could spark new competition, we have a formidable IP barrier including patent applications on fundamental inventions and dozens of trade secret processes.
Next generation food testing
SnapDNA enables safer and fresher food while reducing cost and risk for food companies. We enable rapid identification and isolation of pathogens before a contamination can become an outbreak. We are incorporating metadata-rich, cloud-based data and predictive analytics to prevent contaminations across the industry. We allow real-time monitoring of pathogen testing for a food company across all of its facilities, delivering the information every food safety professional requires and every food company needs. We have the vision, technology, and products to capitalize on the inevitable change to rapid analysis in the existing, recession-proof, $10B food pathogen testing market.
We invite you to join us.
Successfully raised $3M+ in seed rounds
SnapDNA has raised over $3M in prior rounds of seed funding.
SnapDNA founders have personally contributed significantly while investing 8 years developing dozens of fundamental technologies required for our success. Our seed investors include thought leaders and key executives instrumental in the success of some of the Silicon Valley’s most successful companies including Intel, Apple and Genentech. With our commercial product designed and the company poised for a 2021 launch, SnapDNA is doing its first, and likely last, crowdfunding round with this Republic offering to enable others to participate in our upcoming success.
SnapDNA has the leadership to execute our vision
David Medin has 30 years of executive and C-level experience. He’s opened opportunities in emerging multi-billion-dollar businesses and has successfully led large global product development teams.
Tom Jacobs has 25 years of sales leadership at food processors including 12 years at Tyson Foods. He’s responsible for over $500M in industry sales.
Veronica De Guzman, Ph. D. is a molecular biologist with 20 years of expertise developing high-sensitivity DNA analysis including a fundamental invention that is used by a $2 billion-dollar DNA sequencing company.
Gabriel Matus has 18 years of process engineering experience. His designs are used in $11B of semiconductor manufacturing equipment.